InvestorsHub Logo
Followers 116
Posts 11877
Boards Moderated 1
Alias Born 03/08/2004

Re: squeak1 post# 32434

Wednesday, 02/20/2013 10:36:33 AM

Wednesday, February 20, 2013 10:36:33 AM

Post# of 39209
Didn't Grable tell you Shimadzu had applied for Australian approval?

On May 14, 2012, we signed a distribution agreement with Shimadzu Medical to market the CTLM® in Australia, New Zealand and the Pacific Islands. Shimadzu Medical Systems (Oceania) Pty Ltd is an Australasian subsidiary of Shimadzu Corporation, Kyoto, Japan. Shimadzu is working towards resubmitting the required information for Therapeutic Goods Administration (TGA). TGA is Australia's regulatory agency for medical drugs and devices.

******

Or Didn't IMDS announce 2 CTLM sales last year? 10Q discloses $26,000 sales in the 6 months ended Dec 31

****
Didn't IMDS claim to have shipped a CTLM to China?


In December 2011, we received an order for one CTLM® system with a deposit of $50,000 from our exclusive distributor, ID Matrix, which was initially scheduled to ship to China during the first week of January 2012. The distributor was not ready to take delivery so we will wait for their instructions for delivery. As of the date of this report we have not received any indication from the distributor that their customer is ready to receive and install the CTLM® system in their territory. We have no timeframe for delivery or if this sale will ever be completed.


*****
Or that they have ceased signing on new hospitals ...(because they have no money to build and ship machines)

We have temporarily discontinued discussions with other hospitals and clinics wishing to participate in our clinical collaboration program and plan to resume discussions if we secure the necessary funding to continue the program. We have been commercializing the CTLM® in many global markets and we previously announced our plans to set up this network to foster research and to promote the technology in local markets. We will continue to support similar programs outside of the United States if and when we are able to allocate funds for these programs. These investments have the potential to accelerate CTLM® market acceptance while providing valuable clinical experiences.

*************************



#1). You have money. Other people want it. All of it!

#2). You want easy money. So does everybody else. They'll get it, too....yours! (and all of it!)

#3). You tell yourself you're smart. You won't lose your money. Fact: Other people are smarter,

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.